SCHEMBL7857463

SCHEMBL7857463

CC(C)(C)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.53
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
PGK1 P00558 1/20 0.35
ACHE P22303 3/20 0.33
BCHE P06276 2/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
GLP1R P43220 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
TRPA1 O75762 2/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18926214 0.82 KHK (0.61) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7859690 0.81 KHK (0.45) KHKALDH1A1SMN1; SMN2ACHEBCHE
SCHEMBL2539243 0.81 KHK (0.49) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14909350 0.79 KHK (0.54) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14928602 0.76 KHK (0.44) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL16169029 0.76 KHK (0.50) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14927613 0.76 KHK (0.50) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14928506 0.76 KHK (0.50) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14928564 0.76 KHK (0.50) KHKALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL14677256 0.76 KHK (0.43) KHKALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0911327-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2001-12-05 EP disclosed
US-6156903-A Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-12-05 US disclosed
US-6133284-A EXCELLENT BACTERICIDAL PROPERTIES AND ORAL ABSORPTION; INFECTIONS FROM GRAMNEGATIVE AND -POSITIVE BACTERIA; INTESTINAL ABSORPTION, METABOLIC STABILITY; SIDE EFFECT REDUCTION; NONPHOTOTOXICITY AND NONCYTOTOXICITY WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
EP-0992501-A2 Pyridonecarboxylic acid derivatives as antibacterial agents WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
US-5998436-A Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredient WAKUNAGA PHARMACEUTICALS CO., LTD. (JP) 1999-12-07 US disclosed
EP-0952151-A2 Intermediates for use in preparing novel pyridonecarboxylic acid derivatives or their salts WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-10-27 EP disclosed
EP-0911327-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR THEIR SALTS AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-04-28 EP disclosed